申请人:Taisho Pharmaceutical Co., Ltd.
公开号:US04387238A1
公开(公告)日:1983-06-07
The epoxysuccinamic acid compounds of the present invention are prepared by reaction of monoesters of epoxysuccinic acid or monoesters of epoxysuccinic acid chloride with amino compounds. These epoxysuccinamic acid compounds have excellent anti-inflammatory activity, thiol protease inhibitory activity, muscular dystrophy inhibitory activity and anti-hypertensive activity without acceleration of vascular permeability.
本发明的环氧琥珀酰胺酸化合物是通过环氧琥珀酸单酯或环氧琥珀酸氯化物与氨基化合物反应制备的。这些环氧琥珀酰胺酸化合物具有出色的抗炎活性、巯基蛋白酶抑制活性、肌肉营养不良抑制活性和抗高血压活性,而不会加速血管通透性。